Daniel Cagney Selected Research

L 644711 (B-3(+))

4/2010

Economic impact of prescreening on gastroenterology outpatient clinic practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Cagney Research Topics

Disease

7	Neoplasms (Cancer) 01/2024 - 01/2020
4	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 04/2020
3	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2017
2	COVID-19 01/2021 - 04/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
1	Kidney Neoplasms (Kidney Cancer) 07/2023
1	Adenocarcinoma of Lung 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Death (Near-Death Experience) 09/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2010

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2024
1	Temozolomide (Temodar)FDA LinkGeneric 01/2024
1	Biomarkers (Surrogate Marker)IBA 09/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2023
1	MethyltransferasesIBA 09/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	AGuIXIBA 01/2021
1	GadoliniumIBA 01/2021
1	Radiation-Sensitizing AgentsIBA 01/2021
1	Estrogen ReceptorsIBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	human ERBB2 proteinIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Estrogens (Estrogen)FDA Link 01/2020
1	L 644711 (B-3(+))IBA 04/2010

Therapy/Procedure

6	Radiotherapy 07/2023 - 01/2017
5	Therapeutics 09/2023 - 01/2017
2	Re-Irradiation 01/2024 - 01/2023
1	Immunotherapy 01/2024
1	Particle Accelerators 07/2023
1	Precision Medicine 01/2021